Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected Cases
1 other identifier
observational
68
1 country
1
Brief Summary
This will be a cross-sectional descriptive study aimed at evaluating the role of high-resolution computed tomography (HRCT) in diagnosing Idiopathic Pulmonary Fibrosis (IPF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2025
CompletedFirst Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedJuly 2, 2025
June 1, 2025
6 months
June 24, 2025
July 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
high-resolution computed tomography (HRCT)
Idiopathic Pulmonary Fibrosis (IPF) high-resolution computed tomography (HRCT) scans are crucial for diagnosis and assessment of disease severity. HRCT findings typically show a reticular pattern with traction bronchiectasis and honeycombing, predominantly in the subpleural and basal regions of the lungs
12 Months
Interventions
High-resolution computed tomography (HRCT) plays a crucial role in diagnosing and managing Idiopathic Pulmonary Fibrosis (IPF). It helps identify the characteristic pattern of IPF, known as Usual Interstitial Pneumonia (UIP), and can sometimes obviate the need for lung biopsy.
Eligibility Criteria
Idiopathic Pulmonary Fibrosis (IPF): IPF is defined as a chronic, progressive fibrotic interstitial lung disease diagnosed based on clinical evaluation, exclusion of other potential causes, and characteristic radiological findings on high-resolution CT (HRCT).
You may qualify if:
- Patients aged 18 years and above.
- Patients clinically suspected of having IPF.
- Patients referred for HRCT examination.
- Patients who provide informed consent to participate in the study.
You may not qualify if:
- Patients with a known diagnosis of other interstitial lung diseases.
- Patients with comorbid conditions that could mimic IPF.
- Patients who are pregnant.
- Patients with incomplete medical records or imaging studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AYK Hospital
Lahore, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 2, 2025
Study Start
March 17, 2025
Primary Completion
September 1, 2025
Study Completion
February 28, 2026
Last Updated
July 2, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share